1.01
Schlusskurs vom Vortag:
$0.9915
Offen:
$0.9951
24-Stunden-Volumen:
142.79K
Relative Volume:
0.40
Marktkapitalisierung:
$105.52M
Einnahmen:
$241.52M
Nettoeinkommen (Verlust:
$-199.30M
KGV:
-0.805
EPS:
-1.2546
Netto-Cashflow:
$37.06M
1W Leistung:
-5.61%
1M Leistung:
-10.62%
6M Leistung:
-66.67%
1J Leistung:
-60.55%
Definitive Healthcare Corp Stock (DH) Company Profile
Firmenname
Definitive Healthcare Corp
Sektor
Branche
Telefon
508-720-4224
Adresse
492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM
Compare DH vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
DH
Definitive Healthcare Corp
|
1.01 | 98.88M | 241.52M | -199.30M | 37.06M | -1.2546 |
|
VEEV
Veeva Systems Inc
|
159.09 | 24.73B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
TEM
Tempus Ai Inc
|
49.53 | 7.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
46.04 | 8.71B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
81.36 | 6.59B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
WAY
Waystar Holding Corp
|
22.43 | 4.12B | 1.10B | 112.09M | 283.19M | 0.6096 |
Definitive Healthcare Corp Stock (DH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-09-17 | Eingeleitet | BTIG Research | Buy |
| 2024-07-31 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-17 | Herabstufung | Needham | Buy → Hold |
| 2024-01-05 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-07-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-04-19 | Eingeleitet | William Blair | Outperform |
| 2022-12-09 | Eingeleitet | BofA Securities | Neutral |
| 2022-07-06 | Eingeleitet | Needham | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-02-24 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-12-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-10-11 | Eingeleitet | Barclays | Equal Weight |
| 2021-10-11 | Eingeleitet | Canaccord Genuity | Hold |
| 2021-10-11 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-11 | Eingeleitet | Deutsche Bank | Hold |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-10-11 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-10-11 | Eingeleitet | Stifel | Buy |
Alle ansehen
Definitive Healthcare Corp Aktie (DH) Neueste Nachrichten
Definitive Healthcare (DH) price target decreased by 29.12% to 2.82 - MSN
DH SEC FilingsDefinitive Healthcare Corp. 10-K, 10-Q, 8-K Forms - Stock Titan
BofA cuts Definitive Healthcare stock price target on weak guidance - Investing.com
Definitive Healthcare Corp. Files Form 8-K with SEC – Company Information, Stock Details, and Compliance Data - Minichart
Definitive Healthcare Ends Spectrum Nomination Rights Agreement - TipRanks
Definitive Healthcare ends nominating agreement with Spectrum following board resignation - Investing.com
Spectrum board nomination rights end at Definitive Healthcare (DH) - Stock Titan
Definitive Healthcare Corp. Files Form 8-K with SEC on March 30, 2026 – Company Details and Filing Information - Minichart
Definitive Healthcare director Jeff Haywood resigns from board and committee By Investing.com - Investing.com South Africa
Definitive Healthcare director Jeff Haywood resigns from board and committee - Investing.com
Definitive Healthcare (DH) CEO has RSU shares withheld for taxes - Stock Titan
Definitive Healthcare (DH) chair has 45,154 shares withheld for RSU tax obligations - Stock Titan
Jeff Haywood resigns from Definitive Healthcare board, leaves Compensation Committee - TradingView — Track All Markets
Director Jeff Haywood exits Definitive Healthcare (DH) board, shrinking seats - Stock Titan
Definitive Healthcare Corp. Announces Resignation of Jeff Haywood from Board and as Member of the Human Capital Management and Compensation Committee, Effective March 30, 2026 - marketscreener.com
Definitive Healthcare Corp. Hits New 52-Week Low at $1.37 - Markets Mojo
DH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
DH Should I Buy - Intellectia AI
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Biogen (BIIB) - The Globe and Mail
Barclays Has Lowered Expectations for Definitive Healthcare (NASDAQ:DH) Stock Price - MarketBeat
DH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Bearish Setup: Will Definitive Healthcare Corp benefit from current market trends2026 Trends & Verified Short-Term Trading Plans - baoquankhu1.vn
Definitive Healthcare Corp. (NASDAQ:DH) Given Average Rating of “Reduce” by Brokerages - Defense World
Definitive Healthcare Corp. (NASDAQ:DH) Given Average Rating of "Reduce" by Brokerages - MarketBeat
Definitive Healthcare Corp. (DH) matches Q4 earnings estimates - MSN
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY) and Intuitive Surgical (ISRG) - The Globe and Mail
Definitive Healthcare (NASDAQ:DH) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Institution Moves: Is Definitive Healthcare Corp forming a double bottom2026 Selloffs & Entry Point Confirmation Signals - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), Myomo (MYO) and OS Therapies Incorporated (OSTX) - The Globe and Mail
Definitive Healthcare stock holds at Neutral as revenue declines persist By Investing.com - Investing.com Australia
Definitive Healthcare stock holds at Neutral as revenue declines persist - Investing.com
Definitive Healthcare (NASDAQ:DH) Cut to Strong Sell at Zacks Research - Defense World
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Definitive Healthcare Corp. Hits New 52-Week Low at $1.10 - Markets Mojo
Zacks Research Downgrades Definitive Healthcare (NASDAQ:DH) to Strong Sell - MarketBeat
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 - Yahoo Finance
Gap Down: Can Definitive Healthcare Corp outperform under higher oil pricesJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Definitive Healthcare Stock Quote, Share Price, News and Analysis - Longbridge
Definitive Healthcare (DH) Earnings Transcript - AOL.com
Pullback Watch: Will Definitive Healthcare Corp benefit from current market trendsPortfolio Update Report & Weekly Watchlist of Top Performers - baoquankhu1.vn
Definitive Healthcare Corp. Hits New 52-Week Low at $1.14 - Markets Mojo
Tax-withholding share transfer by Definitive Healthcare (DH) CEO Coop - Stock Titan
Definitive Healthcare Earnings Call Balances Profit and Pressure - TipRanks
Canaccord Genuity Group Lowers Definitive Healthcare (NASDAQ:DH) Price Target to $3.00 - Defense World
DH PE Ratio & Valuation, Is DH Overvalued - Intellectia AI
Definitive Healthcare (NASDAQ:DH) Stock Rating Lowered by Wall Street Zen - Defense World
Definitive Healthcare Q4 2025 slides: profit gains amid revenue decline - Investing.com Australia
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Stephens cuts Definitive Healthcare stock price target on revenue decline - Investing.com Nigeria
Finanzdaten der Definitive Healthcare Corp-Aktie (DH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):